OpenToolslogo
ToolsExpertsSubmit a Tool
AdvertiseLearn AI
  1. home
  2. news
  3. tags
  4. crispr

crispr

5+ articles
Colossal BiosciencesDigital HealthEconomic ImpactElon MuskGaza
Loading news...

Related Topics

Colossal BiosciencesDigital HealthEconomic ImpactElon MuskGazaInnovationNeuralinkScienceSeries C FundingTechnological Advancements

Most Read

1
Elon Musk Ignites Dino Dreams with 'Jurassic Park' Startup Endorsement!
2
Breakthroughs on the Horizon: Gene Editing, Alzheimer's Therapy, and AI in Genetic Diagnosis
3
Global Turmoil: Unpacking the Twin Crises of Ukraine and Gaza
4
Revolutionary Genetic Breakthrough Promises to Change Medicine Forever!
5
Colossal Biosciences Achieves Decacorn Status with $200M Series C Funding

Stay in the loop

Weekly updates on tools, models, and the companies building them.

Subscribe free

Footer

Company name

The right AI tool is out there. We'll help you find it.

LinkedInX

Knowledge Hub

  • News
  • Resources
  • Newsletter
  • Blog
  • AI Tool Reviews
  • YouTube Summary
  • YouTube Transcript Generator

Industry Hub

  • AI Companies
  • AI Tools
  • AI Models
  • MCP Servers
  • AI Tool Categories
  • Top AI Use Cases

For Builders

  • Submit a Tool
  • Experts & Agencies
  • Advertise
  • Compare Tools
  • Favourites

Legal

  • Privacy Policy
  • Terms of Service

© 2026 OpenTools - All rights reserved.

Elon Musk Ignites Dino Dreams with 'Jurassic Park' Startup Endorsement!

Elon Musk's enthusiastic response to a viral 'Jurassic Park' startup idea by Nikita Bier has reignited debates on de-extinction and biotech breakthroughs. The idea, although scientifically improbable for true dinosaur revival, has garnered attention due to Musk's influence. Explore the feasibility, scientific discourse, and ethical considerations surrounding this intriguing topic.

Mar 7
Elon Musk Ignites Dino Dreams with 'Jurassic Park' Startup Endorsement!

Breakthroughs on the Horizon: Gene Editing, Alzheimer's Therapy, and AI in Genetic Diagnosis

Explore how CRISPR therapeutics, Alzheimer's artificial memory implants, AI-driven genetic diagnostics, smart contact lenses, and protein-based synapse engineering are revolutionizing healthcare and technology in 2025. With transformative impacts across drug development, neuroscience, wearable tech, and beyond, these innovations promise to redefine treatment approaches, diagnostics accuracy, and wearable capabilities.

Aug 19
Breakthroughs on the Horizon: Gene Editing, Alzheimer's Therapy, and AI in Genetic Diagnosis

Global Turmoil: Unpacking the Twin Crises of Ukraine and Gaza

In a rapidly changing geopolitical landscape, the ongoing conflicts in Ukraine and Gaza are reshaping global security dynamics, affecting economies, and exacerbating humanitarian woes. With Poland's crucial presidential election unfolding amidst these tensions, and domestic incidents in the US underscoring international security concerns, the stability of global systems hangs in the balance. Meanwhile, technological advances in fields such as CRISPR and AI language generation continue to push boundaries, creating both promise and perplexity for future development.

May 18
Global Turmoil: Unpacking the Twin Crises of Ukraine and Gaza

Revolutionary Genetic Breakthrough Promises to Change Medicine Forever!

A new study published in Nature reveals an unprecedented breakthrough in genetic engineering that could radically transform how we approach treatment for genetic disorders. Leveraging cutting-edge CRISPR technology, scientists have developed a method to precisely edit and repair genes, a move that experts believe could eliminate various hereditary diseases in future generations.

May 7
Revolutionary Genetic Breakthrough Promises to Change Medicine Forever!

Colossal Biosciences Achieves Decacorn Status with $200M Series C Funding

Colossal Biosciences, the trailblazer in de-extinction technology, has secured an impressive $200 million in Series C funding, propelling its valuation to decacorn status at $10.2 billion. Founded in 2021, the company leverages CRISPR gene editing to revive extinct species like the woolly mammoth and dodo. With total funding reaching $435 million, Colossal aims to further advance its genetic engineering technologies, with promising applications in conservation, healthcare, and evolutionary biology.

Jan 17
Colossal Biosciences Achieves Decacorn Status with $200M Series C Funding